Evaluation of a simplified optimizer for MR-guided adaptive RT in case of pancreatic cancer.


Journal

Journal of applied clinical medical physics
ISSN: 1526-9914
Titre abrégé: J Appl Clin Med Phys
Pays: United States
ID NLM: 101089176

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 14 03 2019
revised: 19 07 2019
accepted: 22 07 2019
pubmed: 25 8 2019
medline: 27 2 2020
entrez: 25 8 2019
Statut: ppublish

Résumé

Magnetic resonance-guided adaptive radiotherapy (MRgART) is considered a promising resource for pancreatic cancer, as it allows to online modify the dose distribution according to daily anatomy. This study aims to compare the dosimetric performance of a simplified optimizer implemented on a MR-Linac treatment planning system (TPS) with those obtained using an advanced optimizer implemented on a conventional Linac. Twenty patients affected by locally advanced pancreatic cancer (LAPC) were considered. Gross tumor volume (GTV) and surrounding organ at risks (OARs) were contoured on the average 4DCT scan. Planning target volume was generated from GTV by adding an isotropic 3 mm margin and excluding overlap areas with OARs. Treatment plans were generated by using the simple optimizer for the MR-Linac in intensity-modulated radiation therapy (IMRT) and the advanced optimizer for conventional Linac in IMRT and volumetric modulated arc therapy (VMAT) technique. Prescription dose was 40 Gy in five fractions. The dosimetric comparison was performed on target coverage, dosimetric indicators, and low dose diffusion. The simplified optimizer of MR-Linac generated clinically acceptable plans in 80% and optimal plans in 55% of cases. The number of clinically acceptable plans obtained using the advanced optimizer of the conventional Linac with IMRT was the same of MR-Linac, but the percentage of optimal plans was higher (65%). Using the VMAT technique, it is possible to obtain clinically acceptable plan in 95% and optimal plans in 90% of cases. The advanced optimizer combined with VMAT technique ensures higher target dose homogeneity and minor diffusion of low doses, but its actual optimization time is not suitable for MRgART. Simplified optimization solutions implemented in the MR-Linac TPS allows to elaborate in most of cases treatment plans dosimetrically comparable with those obtained by using an advanced optimizer. A superior treatment plan quality is possible using the VMAT technique that could represent a breakthrough for the MRgART if the modern advancements will lead to shorter optimization times.

Identifiants

pubmed: 31444952
doi: 10.1002/acm2.12697
pmc: PMC6753732
doi:

Types de publication

Evaluation Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

20-30

Informations de copyright

© 2019 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine.

Références

Radiother Oncol. 2017 Dec;125(3):470-477
pubmed: 28939180
Radiat Oncol. 2018 Mar 24;13(1):51
pubmed: 29573744
PLoS One. 2016 Dec 29;11(12):e0169202
pubmed: 28033342
Med Phys. 2015 Dec;42(12):7182-9
pubmed: 26632072
Ann Oncol. 2015 Apr;26(4):779-786
pubmed: 25623049
Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):1166-71
pubmed: 22543215
Cancer J. 2011 May-Jun;17(3):182-9
pubmed: 21610472
Cureus. 2017 Aug 27;9(8):e1618
pubmed: 29104835
Med Phys. 2016 Jul;43(7):4040
pubmed: 27370123
Med Phys. 2010 Aug;37(8):4078-101
pubmed: 20879569
Phys Med Biol. 2009 Jun 21;54(12):N229-37
pubmed: 19451689
Semin Radiat Oncol. 2014 Jul;24(3):207-9
pubmed: 24931095
J Clin Oncol. 2013 Mar 1;31(7):886-94
pubmed: 23341531
J Neurosurg. 2006 Dec;105 Suppl:194-201
pubmed: 18503356
Pract Radiat Oncol. 2018 Sep - Oct;8(5):e312-e321
pubmed: 29703704
JAMA. 2016 May 3;315(17):1844-53
pubmed: 27139057
Semin Radiat Oncol. 2014 Jul;24(3):196-9
pubmed: 24931092
Strahlenther Onkol. 2012 Jan;188(1):97-9
pubmed: 22234506
Radiother Oncol. 2017 Dec;125(3):439-444
pubmed: 28811038
Radiother Oncol. 2017 Nov;125(2):273-279
pubmed: 29079310
Phys Imaging Radiat Oncol. 2018 Jul 21;7:1-8
pubmed: 33458398

Auteurs

Davide Cusumano (D)

Dipartimento di diagnostica per immagini, radioterapia oncologica ed ematologia, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Roma, Italy.

Luca Boldrini (L)

Dipartimento di diagnostica per immagini, radioterapia oncologica ed ematologia, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Roma, Italy.

Sebastiano Menna (S)

Dipartimento di diagnostica per immagini, radioterapia oncologica ed ematologia, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Roma, Italy.

Stefania Teodoli (S)

Dipartimento di diagnostica per immagini, radioterapia oncologica ed ematologia, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Roma, Italy.

Elisa Placidi (E)

Dipartimento di diagnostica per immagini, radioterapia oncologica ed ematologia, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Roma, Italy.

Giuditta Chiloiro (G)

Dipartimento di diagnostica per immagini, radioterapia oncologica ed ematologia, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Roma, Italy.

Lorenzo Placidi (L)

Dipartimento di diagnostica per immagini, radioterapia oncologica ed ematologia, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Roma, Italy.

Francesca Greco (F)

Dipartimento di diagnostica per immagini, radioterapia oncologica ed ematologia, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Roma, Italy.

Gerardina Stimato (G)

Dipartimento di diagnostica per immagini, radioterapia oncologica ed ematologia, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Roma, Italy.

Francesco Cellini (F)

Dipartimento di diagnostica per immagini, radioterapia oncologica ed ematologia, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Roma, Italy.

Vincenzo Valentini (V)

Dipartimento di diagnostica per immagini, radioterapia oncologica ed ematologia, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Roma, Italy.
Istituto di Radiologia, Università Cattolica del Sacro Cuore, Roma, Italy.

Luigi Azario (L)

Dipartimento di diagnostica per immagini, radioterapia oncologica ed ematologia, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Roma, Italy.
Istituto di Fisica, Università Cattolica del Sacro Cuore, Roma, Italy.

Marco De Spirito (M)

Dipartimento di diagnostica per immagini, radioterapia oncologica ed ematologia, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Roma, Italy.
Istituto di Fisica, Università Cattolica del Sacro Cuore, Roma, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH